Showing 1 - 5 results of 5 for search 'Mike Mattie', query time: 0.03s Refine Results
  1. 1
    Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data

    Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data by Davide Bedognetti, David M Barrett, Jorge Andrade, Sabina Adhikary, Mike Mattie, Kelly Speth, Jin Xie, Rhine Shen, Qinghua Song, Jenny J Kim

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy

    Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy by Yoganand Balagurunathan, Zhouping Wei, Jin Qi, Zachary Thompson, Erin Dean, Erin Dean, Hong Lu, Hong Lu, Saran Vardhanabhuti, Salvatore Corallo, Jung W. Choi, Jenny J. Kim, Mike Mattie, Michael Jain, Frederick L. Locke

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire

    Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire by Giulia Cheloni, Dimitra Karagkouni, Yered Pita-Juarez, Daniela Torres, Eleni Kanata, Jessica Liegel, Zachary Avigan, Isabella Saldarriaga, Georges Chedid, Kathrine Rallis, Brodie Miles, Gayatri Tiwari, Jenny Kim, Mike Mattie, Jacalyn Rosenblatt, Ioannis S. Vlachos, David Avigan

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma

    Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma by Kun Yun, R. Leo Sakemura, Ismail Can, Omar Gutierrez Ruiz, Ekene J. Ogbodo, Shuwen Zhang, Ateka Saleh, Truc N. Huynh, Claudia Manriquez Roman, Olivia L. Sirpilla, Carli M. Stewart, James H. Girsch, Jennifer M. Feigin, Long Mai, Hong Xia, Brooke Kimball, Lionel A. Kankeu Fonkoua, Mehrdad Hefazi, Michael W. Ruff, Fariborz Rakhshan Rohakhtar, Vernadette Simon, Elizabeth L. Siegler, Mike Mattie, Sao-Mai Nguyen-Mau, Simone Filosto, Saad S. Kenderian

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival

    Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival by Jennifer J. Gile, Patrizia Mondello, Zixing Wang, Ying Li, Radhika Bansal, Sangeetha Gandhi, Henan Zhang, Elham Babadi, Kodi Martinez, Gabrielle McCoy, Zuoyi Shao, Kevin Regan, Matthew A. Hathcock, Panwen Wang, Junwen Wang, Abdullah S. Al Saleh, Gordon Ruan, Stephen M. Ansell, N. Nora Bennani, Patrick B. Johnston, Jonas Paludo, Jose C. Villasboas-Bisneto, Arushi Khurana, Urshila Durani, Yucai Wang, Paul J. Hampel, Allison Rosenthal, Javier Munoz, Eider Moreno, Januario E. Castro, Hemant S. Murthy, Mohamed Kharfan-Dabaja, Saad S. Kenderian, Jenny J. Kim, Rhine Shen, Mike Mattie, Yi Lin, Thomas E. Witzig

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: